- Home
- OSK vs BPMC Comparison
OSK vs BPMC Comparison
Compare OSK & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSK
- BPMC
- Stock Information
- Founded
- OSK 1917
- BPMC 2008
- Country
- OSK United States
- BPMC United States
- Employees
- OSK N/A
- BPMC N/A
- Industry
- OSK Auto Manufacturing
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- OSK Consumer Discretionary
- BPMC Health Care
- Exchange
- OSK Nasdaq
- BPMC Nasdaq
- Market Cap
- OSK 5.6B
- BPMC 5.8B
- IPO Year
- OSK N/A
- BPMC 2015
- Fundamental
- Price
- OSK $99.22
- BPMC $101.35
- Analyst Decision
- OSK Buy
- BPMC Buy
- Analyst Count
- OSK 14
- BPMC 18
- Target Price
- OSK $114.93
- BPMC $125.88
- AVG Volume (30 Days)
- OSK 707.4K
- BPMC 789.4K
- Earning Date
- OSK 04-30-2025
- BPMC 05-01-2025
- Dividend Yield
- OSK 2.06%
- BPMC N/A
- EPS Growth
- OSK N/A
- BPMC N/A
- EPS
- OSK 9.37
- BPMC N/A
- Revenue
- OSK $10,499,200,000.00
- BPMC $562,121,000.00
- Revenue This Year
- OSK N/A
- BPMC $44.49
- Revenue Next Year
- OSK $4.94
- BPMC $33.04
- P/E Ratio
- OSK $10.59
- BPMC N/A
- Revenue Growth
- OSK 5.69
- BPMC 99.19
- 52 Week Low
- OSK $76.82
- BPMC $73.04
- 52 Week High
- OSK $118.39
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- OSK 57.51
- BPMC 56.34
- Support Level
- OSK $96.03
- BPMC $94.38
- Resistance Level
- OSK $101.09
- BPMC $102.52
- Average True Range (ATR)
- OSK 2.13
- BPMC 3.77
- MACD
- OSK -0.02
- BPMC -0.38
- Stochastic Oscillator
- OSK 43.81
- BPMC 79.29
About OSK Oshkosh Corporation (Holding Company)Common Stock
Oshkosh Corp is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms. The company had manufactured joint light tactical vehicles for the U.S. Department of Defense. The company reports in three segments: Access, Vocational and Defense. It derives maximum revenue from Access Segment.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.